Navigation Links
Sihuan Pharmaceutical Announces 2013 Interim Results
Date:8/26/2013

e Group has received Approval for Clinical Trials for a total of five Category 1 innovative drugs from the China State Food and Drug Administration ("CFDA"), including, Benapene, Imigliptin Dihydrochloride and Anaprazole Sodium. In addition, L-Phencynonate Hydrochloride, a Category 1 innovative drug, and Cinepazide Mesilate, a Category 4 exclusive new drug are progressing as planned. The collaborative development project with NeuroVive, innovative CCV drugs CicloMulsion and Neurostat, are in progress as planned towards clinical trials. CicloMulsion is filing application for Approval for Clinical Trials in China.

For the aspect of generic drugs, after gaining production licenses for Roxatidine, a first-to-market exclusive generic drug, and Nalmefene Hydrochloride Injection, a Category 3.1 generic drug, the products successfully passed final inspections and were officially launched. Development of other Category 3.1 generic drugs in the pipeline such as Levetiracetam injection, Lacosamide, and Aprepitant are also in progress as planned. Including these three drug development projects, the Group has a total of 17 Category 3.1 first-to-market generic drug projects under development. In addition, production license applications were filed for two other generic drugs during the Period and approvals from CFDA are expected to be issued by the end of 2013.

Production and Quality ManagementIn compliance with the new Good Manufacturing Practice ("GMP") standards, upgrades of the Company's production bases in Beijing, Jilin and Liaoning are approaching completion. The Group plans to apply for new GMP standard certification in September 2013. The Company's Active Pharmacentical Ingredients production facility, Langfang Gaobo Jingband established cooperation with the largest Canadian-owned pharmaceutical company Apotex Inc. during the Period. More importantly, the
'/>"/>

SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
2. Sihuan Pharmaceutical Announces 2012 Annual Results
3. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
4. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
5. Sihuans First-to-market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production
6. Sihuan Pharmaceutical Announces 2012 Interim Results
7. Sihuans First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
8. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
9. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
10. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
11. Par Pharmaceutical Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical care ... technology to help fight deadly inflammation in critically-ill ... today announced the appointment of Dr. Gregory ... Senior Vice President of Clinical Development, effective January ... Russo is an accomplished pediatric cardiothoracic surgeon ...
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... addition of the "US Self-monitoring Blood Glucose Market" ... http://photos.prnewswire.com/prnh/20130307/600769 This market insight focuses ... in the United States . Reimbursement ... studied. Thorough product analyses for more than 73 SMBG ...
(Date:12/22/2014)...  ConvaTec, a privately-held medical products and technologies company, ... Chief Executive Officer of the company, effective December 22, ... .  "The Board of Directors of ConvaTec thanks Mr. ... past three years," said Magnus Lundberg , the ... that the company is well positioned for the future."  ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... - NEOPHARM, Inc.,(Nasdaq: NEOL) today reported findings ... metastatic colorectal cancer patients with its,drug product ... While the interim analysis of data following ... patients demonstrated,disease stabilization, the study did not ...
... Science Closer to Targeted, Improved Therapies , BETHESDA, Md., ... Abuse (NIDA), part of the National,Institutes of Health, have ... person's ability to abstain from smoking. The,breakthrough research was ... and a team led by Dr. Jed Rose at ...
Cached Medicine Technology:NeoPharm Provides Update on LE-SN38 Program 2NIDA Study Identifies Genes That Might Help Some People Abstain,from Smoking 2NIDA Study Identifies Genes That Might Help Some People Abstain,from Smoking 3
(Date:12/25/2014)... is common during the holidays, but there are strategies that ... "Don,t arrive at a party hungry. It may seem logical ... a party, but deprivation leads to hunger, and hunger leads ... in Mount Kisco, N.Y., said in a hospital news release. ... even to have a snack before attending a party when ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... be closing in on a "fountain of youth" drug that ... of older adults, a new study suggests. Seniors received ... drug that targets a genetic signaling pathway linked to aging ... The experimental medication, a version of the ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Thousands of ... move forward in a number of multidistrict litigations currently ... Virginia, Bernstein Liebhard LLP reports. According to an Order ... to convene a Joint Status Conference in all of ... Parties have been directed to submit a proposed agenda ...
(Date:12/25/2014)... December 25, 2014 Plugin creators from ... 5k. A fully customizable business presentation tool made specifically ... the ProFire 5k business tool, users can now display ... CEO of Pixel Film Studios. “ProFire 5k gives users ... to add professionalism to a presentation” , Pixel Film ...
(Date:12/25/2014)... Each year trauma accounts for approximately ... admissions across the nation (according to the Centers ... National Hospital Ambulatory Medical Care Survey collected data ... 2010. They estimated that there were between 3.5 and ... primary diagnosis of broken bone or fracture. , ...
Breaking Medicine News(10 mins):Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... 7, 2009, the Boston District Court dismissed the "Diomed" lawsuit ... a settlement agreement with Dr. Luis Navarro. This patent ... the use of lasers for endovenous ablation. CoolTouch will ... laser sales and accessories that potentially allow vein wall contact ...
... Awareness Month raises visibility of 900 active groups; National Parkinson Foundation ... ... 13, 2009 - For individuals diagnosed with Parkinson,s disease, self-care and ... and support groups provide an important component for this self-care, according ...
... Americas Watchdog and its Homeowners Consumer Center have been ... Toxic Chinese drywall that was first introduced into the ... certain this involves 100,000,s of homeowners, in all US ... toxic Chinese drywall is corroding copper, metal, and most ...
... are less likely to receive recommended chemotherapy and surgery than ... of lessening. That is the conclusion of a new study ... , a peer-reviewed journal of the American Cancer Society. The ... treatments for black patients and to educate them about the ...
... first time used tiny molecules called microRNAs to help turn ... cells are pluripotent, meaning that, like embryonic stem cells, they ... body. , The findings suggest that scientists will soon ... in laboratory experiments to induce pluripotency in adult cells. This ...
... for EpilepsyThe Toll of Epilepsy Has Been Overlooked - and the ... we need more of a cancerlike sensibility around epilepsy," Newsweek ... cover, " The Mystery of Epilepsy" (on newsstands Monday, April ... do not hesitate to invest the search for a cure for ...
Cached Medicine News:Health News:CoolTouch Inc. Settles Diomed Lawsuit, Files Re-examination Request for Cynosure '873 Patent 2Health News:Parkinson's Support Groups Grow Nationwide 2Health News:Americas Watchdog Calls On President Obama To Get Involved With The Toxic Chinese Drywall Disaster--Now 2Health News:Americas Watchdog Calls On President Obama To Get Involved With The Toxic Chinese Drywall Disaster--Now 3Health News:Americas Watchdog Calls On President Obama To Get Involved With The Toxic Chinese Drywall Disaster--Now 4Health News:Racial disparities persist in the treatment of lung cancer 2Health News:UCSF team closer to creating safe embryonic-like stem cells 2Health News:UCSF team closer to creating safe embryonic-like stem cells 3Health News:NEWSWEEK Cover: The Mystery of Epilepsy 2Health News:NEWSWEEK Cover: The Mystery of Epilepsy 3
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Digitoxin in human serum....
For the quantitative in vitro determination of Phenytoin in human serum....
For the quantitative in vitro determination of Phenobarbital in human serum....
Medicine Products: